Literature DB >> 1999035

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.

J W Yarnell1, I A Baker, P M Sweetnam, D Bainton, J R O'Brien, P J Whitehead, P C Elwood.   

Abstract

BACKGROUND: Recent studies have suggested that hemostatic factors and white blood cell count are predictive of ischemic heart disease (IHD). The relations of fibrinogen, viscosity, and white blood cell count to the incidence of IHD in the Caerphilly and Speedwell prospective studies are described. METHODS AND
RESULTS: The two studies have a common core protocol and are based on a combined cohort of 4,860 middle-aged men from the general population. The first follow-up was at a nearly constant interval of 5.1 years in Caerphilly and 3.2 years in Speedwell; 251 major IHD events had occurred. Age-adjusted relative odds of IHD for men in the top 20% of the distribution compared with the bottom 20% were 4.1 (95% confidence interval, 2.6-6.5) for fibrinogen, 4.5 (95% confidence interval, 2.8-7.4) for viscosity, and 3.2 (95% confidence interval, 2.0-4.9) for white blood cell count. Associations with IHD were similar in men who had never smoked, exsmokers, and current smokers, and the results suggest that at least part of the effect of smoking on IHD is mediated through fibrinogen, viscosity, and white blood cell count. Multivariate analysis shows that white blood cell count is an independent risk factor for IHD as is either fibrinogen or viscosity, or possibly both. Jointly, these three variables significantly improve the fit of a logistic regression model containing all the main conventional risk factors. Further, a model including age, smoking habits, fibrinogen, viscosity, and white blood cell count predicts IHD as well as one in which the three hemostatic/rheological variables are replaced by total cholesterol, diastolic pressure, and body mass index.
CONCLUSION: Jointly, fibrinogen, viscosity, and white blood cell count are important risk factors for IHD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999035     DOI: 10.1161/01.cir.83.3.836

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  115 in total

Review 1.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

2.  Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study.

Authors:  D P Strachan; D Carrington; M A Mendall; B K Butland; P M Sweetnam; P C Elwood
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

3.  Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study.

Authors:  D P Strachan; D Carrington; M A Mendall; L Ballam; J Morris; B K Butland; P M Sweetnam; P C Elwood
Journal:  BMJ       Date:  1999-04-17

4.  Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort.

Authors:  P C Elwood; S Renaud; A D Beswick; J R O'Brien; P M Sweetnam
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

5.  [Cardiovascular risk factors in diabetic nephropathy].

Authors:  J Zimmermann; L Schramm; E Mulzer; E Heidbreder; H A Henrich; C Wanner
Journal:  Med Klin (Munich)       Date:  1997-02-15

Review 6.  [Rheological determinants of end-organ damage].

Authors:  M Leschke; W Klimek; F Jung
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

7.  Lipid profile, haemostatic variables and angiographically-defined coronary artery disease: a cross-sectional study in an Irish population.

Authors:  J Galvin; M Codd; S Leavy; D Sugrue
Journal:  Ir J Med Sci       Date:  1996 Apr-Jun       Impact factor: 1.568

8.  Rheumatoid arthritis, periodontal disease and coronary artery disease.

Authors:  S Abou-Raya; A Abou-Raya; A Naim; H Abuelkheir
Journal:  Clin Rheumatol       Date:  2007-08-29       Impact factor: 2.980

9.  Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.

Authors:  H S Gurm; D L Bhatt; A M Lincoff; J E Tcheng; D J Kereiakes; N S Kleiman; G Jia; E J Topol
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

10.  Ischaemic heart disease: association with haematocrit in the British Regional Heart Study.

Authors:  G Wannamethee; A G Shaper; P H Whincup
Journal:  J Epidemiol Community Health       Date:  1994-04       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.